BLA 138: Can Exercise Decrease Death From Colon Cancer? (CHALLENGE Trial)
Building Lifelong AthletesShow Notes
Could one of the most effective ways to boost survival after a colon cancer diagnosis be exercise? In this episode, I dive deep into the groundbreaking CHALLENGE Trial, a landmark study that explored how a structured exercise program impacts survival rates for colon cancer patients. We'll break down the study's surprising results, including a 28% relative reduction in disease-free survival events and a 37% relative reduction in the risk of death, and discuss what this could mean for the future of cancer care.
Want a checklist to know the most important areas of health you need to take care of? Click Here: https://www.jrennickemd.com/necessaryninepdf
CHAPTERS: 00:00 - Intro 00:34 - Old Evidence 01:40 - CHALLENGE Trial Intro 02:51 - Population, Invervention, Comparators, Outcomes 04:30 - Healthier Survivor Problem 05:22 - No True “Control” Group 06:55 - Main Results 08:08 - Fitness Outcomes 10:01 - Safety and Side Effects 11:07 - What Explains These Results? 12:03 - Comparing These Results With Older Results 13:27 - New Standard of Care? 15:03 - Future Areas of Research 16:11 - My Takeaways 17:50 - Outro
SELECTED REFERENCES: https://www.nejm.org/doi/full/10.1056/NEJMoa2502760
*Disclaimer* This podcast is for entertainment, education, and informational purposes only. The topics discussed should not solely be used to diagnose, treat , or prevent any condition. The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate. Always seek the advice of your personal physician or qualified health care provider for questions regarding any medical condition.
colon cancer, exercise, cancer survival, CHALLENGE Trial, oncology, cancer research, disease-free survival, structured exercise program, physical activity, cancer treatment, cancer care, evidence-based medicine
More from Building Lifelong Athletes
In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.
Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.
In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.
Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.